HARP – harpoon therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Merck: A High-Conviction Investment For Long-Term Growth [Seeking Alpha]
Harpoon Therapeutics, Inc. (NASDAQ: HARP) had its "neutral" rating re-affirmed by analysts at Citigroup Inc.. They now have a $23.00 price target on the stock, up previously from $13.00.
INVESTIGATION ALERT: Halper Sadeh LLC Investigates HARP, TARO, FFNW
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger – HARP, FGH, BBAI
INVESTIGATION ALERT: Halper Sadeh LLC Investigates HARP, JNPR, TGAN, TAST
Form EFFECT Harpoon Therapeutics,
Form EFFECT Harpoon Therapeutics,
Form EFFECT Harpoon Therapeutics,
Form 4 Harpoon Therapeutics, For: Mar 11 Filed by: New Leaf Biopharma Opportunities II, L.P.
Form 4 Harpoon Therapeutics, For: Mar 11 Filed by: SILVERNAIL LAUREN P
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.